Arundic Acid

CAS No. 185517-21-9

Arundic Acid ( ONO 2506; (R)-2-Propyloctanoic acid )

Catalog No. M23845 CAS No. 185517-21-9

Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 56 In Stock
10MG 87 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Arundic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
  • Description
    Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
  • Synonyms
    ONO 2506; (R)-2-Propyloctanoic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    185517-21-9
  • Formula Weight
    186.3
  • Molecular Formula
    C11H22O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (805.20 mM; Need ultrasonic)
  • SMILES
    CCCCCC[C@H](C(=O)O)CCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tomoyuki Hasegawa, et al. Process Development of ONO-2506:? A Therapeutic Agent for Stroke and Alzheimer's Disease. Org. Process Res. Dev.200372168-171.
molnova catalog
related products
  • 3-hydroxymorindone

    3-hydroxymorindone is a natural product from Morinda citrifolia. 3-hydroxymorindone is a pigment.

  • R 892

    Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.

  • Sterebin A

    Sterebin A may have anti-inflammatory activity.